Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_guideline
|
| gptkbp:appliesTo |
solid tumors
|
| gptkbp:basisFor |
CT scans
imaging studies MRI scans |
| gptkbp:citation |
clinical trials
oncology research |
| gptkbp:compatibleWith |
brain tumors
hematologic malignancies |
| gptkbp:defines |
complete response
partial response progressive disease stable disease |
| gptkbp:developedBy |
European Organisation for Research and Treatment of Cancer
Canadian Cancer Trials Group National Cancer Institute of the United States |
| gptkbp:firstPublished |
2000
|
| gptkbp:fullName |
Response Evaluation Criteria in Solid Tumors
|
| gptkbp:measures |
tumor size
tumor response to treatment |
| gptkbp:updated |
RECIST 1.1
|
| gptkbp:updateYear |
2009
|
| gptkbp:usedFor |
measuring tumor response
|
| gptkbp:usedIn |
oncology
|
| gptkbp:website |
https://recist.eortc.org/
|
| gptkbp:bfsParent |
gptkb:Objective_Response_Rate
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
RECIST criteria
|